Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity
申请人:Hoffmann-La Roche Inc.
公开号:US07547699B2
公开(公告)日:2009-06-16
The present invention refers to chemical compounds of formula (I)
as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1. These compounds can be used for the preparation of medicaments.